AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare
AIM ImmunoTech Inc. Shareholder Equity 2009–2025
AIM ImmunoTech Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- AIM ImmunoTech Inc. shareholder equity as of December 31, 2025: -9.8M, a 640.02% increase year-over-year.
- AIM ImmunoTech Inc. shareholder equity for 2025 were -9.8M, a 640.02% increase from 2024.
- AIM ImmunoTech Inc. shareholder equity for 2024 were -1.3M, a 112.92% decrease from 2023.
- AIM ImmunoTech Inc. shareholder equity for 2023 were 10.2M, a 73.40% decrease from 2022.
- AIM ImmunoTech Inc. shareholder equity for 2022 were 38.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AIM ImmunoTech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-10 |
| 2024 | $-1 |
| 2023 | $10 |
| 2022 | $38 |
| 2021 | $57 |
| 2020 | $61 |
| 2019 | $13 |
| 2018 | $6 |
| 2017 | $9 |
| 2016 | $15 |
| 2015 | $20 |
| 2014 | $25 |
| 2013 | $29 |
| 2012 | $45 |
| 2011 | $38 |
AIM ImmunoTech Inc. Shareholder Equity — FAQ
AIM ImmunoTech Inc. (AIM) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIM's shareholder equity history?
The chart and table above show AIM ImmunoTech Inc.'s shareholder equity by year and by quarter, including the growth rate.